Scoping review identifies factors associated with the onset of infant acute lymphoblastic leukaemia January 31, 2025 Scoping review identifies factors associated with the onset of infant acute lymphoblastic leukaemia
Dr. Josep Maria Ribera, designated Correspondant Academic of the Reial Acadèmia de Medicina de Catalunya February 01, 2021 Dr. Josep Maria Ribera, designated Correspondant Academic of the Reial Acadèmia de Medicina de Catalunya
The Josep Carreras Leukaemia Institute opens a new lab devoted to cellular systems genomics January 21, 2021 The Josep Carreras Leukaemia Institute opens a new lab devoted to cellular systems genomics
New epigenetic targets identified for the potential treatment of multiple myeloma January 18, 2021 New epigenetic targets identified for the potential treatment of multiple myeloma
The INTERCEPT-MDS PhD fellowships to train Europe’s first experts in the emerging field of disease interception are open for applications. January 11, 2021 The INTERCEPT-MDS PhD fellowships to train Europe’s first experts in the emerging field of disease interception are open for applications.
Researchers from the Josep Carreras Institute received one of the five grants awarded worldwide by the Facebook founder’s Foundation to study COVID-19 December 31, 2020 Researchers from the Josep Carreras Institute received one of the five grants awarded worldwide by the Facebook founder’s Foundation to study COVID-19
Cancer cells resistant to treatment are already present before diagnosis of adult leukaemia December 16, 2020 Cancer cells resistant to treatment are already present before diagnosis of adult leukaemia
Discovered a new prognostic marker in a specific subtype of acute lymphoblastic leukemia (ALL) with adverse outcome in infants December 10, 2020 Discovered a new prognostic marker in a specific subtype of acute lymphoblastic leukemia (ALL) with adverse outcome in infants
Discovered the explanation of the patients with “lazarus-like” cancer November 30, 2020 Discovered the explanation of the patients with “lazarus-like” cancer
Seven investigators of the Josep Carreras Institute are recognized between the researchers with the most impact on world level November 26, 2020 Seven investigators of the Josep Carreras Institute are recognized between the researchers with the most impact on world level
Dr. Marcus Buschbeck leads the European Network INTERCEPT-MDS focusing on the shared training and research in Myeloid Diseases November 25, 2020 Dr. Marcus Buschbeck leads the European Network INTERCEPT-MDS focusing on the shared training and research in Myeloid Diseases
